Table 4 |
||||
|
Hazard ratios (95% confidence intervals) for the relationship between estimated glomerular filtration rate and mortality. |
||||
|
Adjustment: |
GFR ≥ 90 |
GFR 60–89 |
GFR 30–59 |
GFR < 30 |
|
|
||||
|
Unadjusted |
ref |
1.44 (0.93–2.25) |
3.35 (2.16–5.20) |
7.52 (4.85–11.66) |
|
Demographic and clinical variables, + reperfusion/revascularization, adjunctive antiplatelet therapy |
ref |
1.23 (0.77–1.95) |
1.51 (0.93–2.46) |
3.35 (2.06–5.44) |
|
Demographic and clinical variables, reperfusion/revascularization, adjunctive antiplatelet therapy |
ref |
1.24 (0.78–1.97) |
1.56 (0.96–2.54) |
3.45 (2.11–5.64) |
|
+ medication eligibility |
||||
|
Demographic and clinical variables, reperfusion/revascularization, adjunctive antiplatelet therapy, medication eligibility, |
ref |
1.24 (0.78–1.97) |
1.56 (0.96–2.56) |
3.56 (2.16–5.87) |
|
+ receipt of medications |
||||
|
|
||||
|
GFR = glomerular filtration rate (ml/min/1.73 m2); ref = referent group |
||||
|
Peterson et al. BMC Cardiovascular Disorders 2009 9:29 doi:10.1186/1471-2261-9-29 |
||||